SERPINA1
Alpha-1-antitrypsin
Also known as: A1A, A1AT, A1AT_HUMAN, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01009
- Gene
- SERPINA1
- Ensembl
- ENSG00000197249
- Chromosome
- 14
- Canonical length
- 418 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
418 residues, UniProt reviewed canonical sequence.
>P01009|SERPINA1
1 MPSSVSWGIL LLAGLCCLVP VSLAEDPQGD AAQKTDTSHH DQDHPTFNKI TPNLAEFAFS
61 LYRQLAHQSN STNIFFSPVS IATAFAMLSL GTKADTHDEI LEGLNFNLTE IPEAQIHEGF
121 QELLRTLNQP DSQLQLTTGN GLFLSEGLKL VDKFLEDVKK LYHSEAFTVN FGDTEEAKKQ
181 INDYVEKGTQ GKIVDLVKEL DRDTVFALVN YIFFKGKWER PFEVKDTEEE DFHVDQVTTV
241 KVPMMKRLGM FNIQHCKKLS SWVLLMKYLG NATAIFFLPD EGKLQHLENE LTHDIITKFL
301 ENEDRRSASL HLPKLSITGT YDLKSVLGQL GITKVFSNGA DLSGVTEEAP LKLSKAVHKA
361 VLTIDEKGTE AAGAMFLEAI PMSIPPEVKF NKPFVFLMIE QNTKSPLFMG KVVNPTQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SERPINA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 31,417 nTPM
Expression across tissuesHPA
Tissue
- liver: 31,417 nTPM
- kidney: 1,076 nTPM
- small intestine: 716 nTPM
- lung: 538 nTPM
- stomach: 334 nTPM
- gallbladder: 331 nTPM
Single-cell type
- hepatocytes: 9,263 nCPM
- enterocytes: 2,752 nCPM
- epididymal efferent duct absorptive cells: 2,184 nCPM
- cholangiocytes: 2,130 nCPM
- neutrophils: 534 nCPM
- alveolar cells type 2: 529 nCPM
Immune cell
- non-classical monocyte: 4,541 nTPM
- intermediate monocyte: 3,414 nTPM
- neutrophil: 2,835 nTPM
- total PBMC: 2,770 nTPM
- classical monocyte: 2,484 nTPM
- myeloid DC: 684 nTPM
Brain region
- cerebral cortex: 35 nTPM
- medulla oblongata: 34 nTPM
- white matter: 26 nTPM
- thalamus: 26 nTPM
- pons: 24 nTPM
- spinal cord: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SERPINA1.
Disease | AllUniProt
Conditions SERPINA1 is implicated in, by any mechanism.
- Alpha-1-antitrypsin deficiency (A1ATD) MIM:613490
Disease | GeneticClinVar
83 pathogenic / likely-pathogenic of 525 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Alpha-1-antitrypsin deficiency
- SERPINA1-related disorder
- Inborn genetic diseases
- Chronic obstructive pulmonary disease
- See cases
Disease | ImmuneIEDB
Conditions an epitope on SERPINA1 was assayed in.
- rheumatoid arthritis B cell
- osteoarthritis B cell
ReferencesPubMed · IEDB
Publications for SERPINA1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.
2020 · J Autoimmun · RCR 1.1 · 19 citations - Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
2012 · Electrophoresis · RCR 0.8 · 27 citations - Antibodies to liver-specific lipoprotein in children with chronic liver disease due to "autoimmune" chronic active hepatitis, cystic fibrosis, and alpha 1-antitrypsin deficiency.
1984 · J Pediatr Gastroenterol Nutr · RCR 0.3 · 5 citations - Effects of D-penicillamine on circulating protein complexes in rheumatoid arthritis and primary biliary cirrhosis.
1981 · J Rheumatol Suppl · RCR 0.2 · 3 citations - Alpha 1 Antitrypsin Suppresses Autoantibody Production and Cellular Autoimmunity in Chronic Graft-Versus-Host Disease (cGVHD) in a Lupus Mouse Model.
2026 · Biomolecules
Reference: B cellIEDB
2 publications
- Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
2020 · Arthritis Rheumatol · RCR 1.7 · 30 citations - Isotypes of autoantibodies against differentially expressed novel malondialdehyde-modified peptide adducts in serum of Taiwanese women with rheumatoid arthritis.
2018 · J Proteomics · RCR 0.4 · 8 citations
Reference: T cellIEDB
1 publication
- Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency.
2017 · Proc Natl Acad Sci U S A · RCR 1.9 · 61 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.37
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
- COPII-coated ER to Golgi transport vesicle
- endoplasmic reticulum
- endoplasmic reticulum lumen
- endoplasmic reticulum-Golgi intermediate compartment membrane
- extracellular exosome
- extracellular matrix
- extracellular region
- extracellular space
- ficolin-1-rich granule lumen
- Golgi apparatus
- platelet alpha granule lumen
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SERPINA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SERPINA1 as an antibody target. Whether an autoantibody or antibody against SERPINA1 could matter depends on whether native SERPINA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SERPINA1 is annotated as secreted, so native SERPINA1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SERPINA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...